Literature DB >> 11594924

Association of moderate polyglutamine tract expansions in the slow calcium-activated potassium channel type 3 with ataxia.

K P Figueroa1, P Chan, L Schöls, C Tanner, O Riess, S L Perlman, D H Geschwind, S M Pulst.   

Abstract

BACKGROUND: The small-conductance calcium-activated potassium channel gene (hSKCa3) contains 2 CAG repeats, 1 of which is highly polymorphic. Although this repeat is not pathologically expanded in patients with schizophrenia, some studies have suggested an allelic association with schizophrenia. CAG expansions in other genes such as the alpha1 subunit of a brain-specific P/Q-type calcium channel gene cause spinocerebellar ataxia type 6, whereas the length of the CAG repeat in the RAI1 gene modifies the age of onset of spinocerebellar ataxia type 2.
OBJECTIVES: To evaluate expansions in the hSKCa3 polyglutamine domain as causative for ataxia, and to study the association between the length of the polyglutamine repeat and the presence of ataxia.
METHODS: We analyzed this repeat in 122 patients with autosomal dominant cerebellar ataxia, or sporadic ataxia, and compared allele distribution with 750 alleles seen in 2 healthy control groups and 172 alleles in patients with Parkinson disease.
RESULTS: The distribution of alleles in ataxia patients and controls was significantly different by Wilcoxon rank test (P <.001). Twenty-two or more polyglutamine tracts were more common in ataxia patients compared with controls by chi2 analysis (P<.001).
CONCLUSION: Longer stretches of polyglutamines in a human potassium channel are not causative for ataxia, but they are associated with the presence of ataxia. There is no association with the presence of Parkinson disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11594924     DOI: 10.1001/archneur.58.10.1649

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  8 in total

Review 1.  K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

Authors:  Heike Wulff; Boris S Zhorov
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

2.  Comparative genetics of functional trinucleotide tandem repeats in humans and apes.

Authors:  Aida M Andrés; Marta Soldevila; Oscar Lao; Victor Volpini; Naruya Saitou; Howard T Jacobs; Ikuo Hayasaka; Francesc Calafell; Jaume Bertranpetit
Journal:  J Mol Evol       Date:  2004-09       Impact factor: 2.395

Review 3.  Molecular and cellular basis of small--and intermediate-conductance, calcium-activated potassium channel function in the brain.

Authors:  P Pedarzani; M Stocker
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

Review 4.  Trafficking of intermediate (KCa3.1) and small (KCa2.x) conductance, Ca(2+)-activated K(+) channels: a novel target for medicinal chemistry efforts?

Authors:  Corina M Balut; Kirk L Hamilton; Daniel C Devor
Journal:  ChemMedChem       Date:  2012-08-07       Impact factor: 3.466

5.  Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia.

Authors:  Vikram G Shakkottai; Chin-hua Chou; Salvatore Oddo; Claudia A Sailer; Hans-Günther Knaus; George A Gutman; Michael E Barish; Frank M LaFerla; K George Chandy
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

6.  A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia.

Authors:  Sabrina Grube; Martin F Gerchen; Bartosz Adamcio; Luis A Pardo; Sabine Martin; Dörthe Malzahn; Sergi Papiol; Martin Begemann; Katja Ribbe; Heidi Friedrichs; Konstantin A Radyushkin; Michael Müller; Fritz Benseler; Joachim Riggert; Peter Falkai; Heike Bickeböller; Klaus-Armin Nave; Nils Brose; Walter Stühmer; Hannelore Ehrenreich
Journal:  EMBO Mol Med       Date:  2011-03-24       Impact factor: 12.137

7.  Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.

Authors:  A Matilla-Dueñas; T Ashizawa; A Brice; S Magri; K N McFarland; M Pandolfo; S M Pulst; O Riess; D C Rubinsztein; J Schmidt; T Schmidt; D R Scoles; G Stevanin; F Taroni; B R Underwood; I Sánchez
Journal:  Cerebellum       Date:  2014-04       Impact factor: 3.847

8.  CAG-encoded polyglutamine length polymorphism in the human genome.

Authors:  Stefanie L Butland; Rebecca S Devon; Yong Huang; Carri-Lyn Mead; Alison M Meynert; Scott J Neal; Soo Sen Lee; Anna Wilkinson; George S Yang; Macaire M S Yuen; Michael R Hayden; Robert A Holt; Blair R Leavitt; B F Francis Ouellette
Journal:  BMC Genomics       Date:  2007-05-22       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.